Patient P-02389

Synthetic patientMETA-24 · Day 128 · 25–34 · M · baseline S11Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

11%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S11
Day 58 SC-12 recommended — Supportive Compound SC-12
Day 59 Patient accepted — Started SC-12 in the companion
Day 65 No meaningful change — Supportive Compound SC-12

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity+6
Toxicity+5
Nutritional resilience+3
Treatment adherence-3

What helped?

Supportive Compound SC-12Day 58
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

93 min

stable · +1.4 vs previous 14 d

Sleep duration

Wearable

7 h

improving · +0.4 vs previous 14 d

Energy level

Daily log

6.5/10

improving · +0.3 vs previous 14 d

Steps

Wearable

9,864

stable · +285 vs previous 14 d

GI burden

Companion

13.6/100

improving · -11.8 vs previous 14 d

Adherence

Companion

92.7 %

stable · -0.2 vs previous 14 d

Sleep quality

Wearable

48/100

improving · +5.6 vs previous 14 d

Glucose, CGM daily mean

CGM

135 mg/dL

improving · -7.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 90 from the failing basin, 8 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -6.1 next day on high-intake days · n 21

Would not help

SC-12 Supportive Compound
already tried, no meaningful change

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-6.1supporter · 95%
Insoluble fibre
+2.2no signal · 34%
Dietary fat load
+1.6no signal · 24%
Histamine load
-1.5no signal · 30%
Caffeine
-1.3no signal · 22%
Simple carbohydrates
-0.6no signal · 15%
Alcohol
-0.5no signal · 15%
Ultra-processed food
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.2 · butyrate capacity 63/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 58 ms
Sleep: 7.9 h
Steps: 10,203
Resting HR: 54 bpm

Daily log: GI score 14, nutritional resilience 68, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02630	49%	S17	NP-02	improved	76
P-02277	47%	S05	AD-05	improved	92
P-02450	47%	S12	NP-02	improved	92
P-02486	46%	S10	ME-01	improved	86
P-02193	45%	S11	CR-01	improved	87
P-02415	44%	S17	GI-04	improved	86
P-02667	44%	S08	HY-01	improved	77
P-02127	42%	S11	SC-12	improved	73
P-02249	42%	S09	DT-01	improved	100
P-02464	41%	S18	ME-01	improved	68
P-02068	39%	S14	NP-02	improved	83
P-02690	38%	S02	ME-01	improved	73